Governance · 15 website notices

Legal centre

Website notices are grouped by their purpose. These notices separate demonstrated website behaviour from unresolved operator, product and service-provider evidence.

Updated

This notice applies to the Luang Pharma corporate website. It is published for information and is not legal or medical advice.

01

Company and website use

Company informationVerified public identity and held particularsTerms of useWebsite scope and transaction boundariesIntellectual propertyBrand, content and third-party-source rightsEditorial policyEvidence hierarchy and correction discipline

02

Privacy and digital handling

Privacy policyCurrent website and email data flowsCookies and browser storageFirst-party runtime and deployment dependenciesPrivacy rightsRequest route without assumed foreign-law scopeSecurity and retentionDemonstrated controls and unresolved infrastructure

03

Medical, safety and regulatory

Medical information noticeReference content versus prescribing informationRegulatory and territorial noticeProduct/site/destination authorisation boundariesPharmacovigilance policyCurrent intake limits and governance requirementsProduct quality and recallsInitial concern and recall-reading guidanceFalsified products and misuse of our nameNo product is on the market; how to report an offer

04

Access and conduct

AccessibilityWCAG 2.2 benchmark and test boundariesEthics and reportingBusiness-conduct concern route and limits